Mga 100 Premix 220 mg Drug Premix is a Health Canada–registered veterinary drug (DIN 00813826) held by Phibro Animal Health Corporation, containing Melengestrol Acetate. Health Canada lists its status as Marketed (status date 28 May 2025). Nexara Health has matched 1 registration of Melengestrol Acetate across 1 other regulated market.
Health Canada registration
| DIN | 00813826 |
|---|---|
| Brand name | Mga 100 Premix |
| Active ingredient | Melengestrol Acetate |
| Strength | 220 mg |
| Dosage form | Drug Premix |
| Route | Oral |
| Company | Phibro Animal Health Corporation |
| Status | Marketed — 28 May 2025 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Melengestrol Acetate registered in other markets
1 registration of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | Melengestrol acetate | Zhejiang Xianju Pharmaceutical Co., Ltd. | Powder | FDA NDC |
See every manufacturer of Melengestrol Acetate worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Mga 100 Premix (DIN 00813826) marketed in Canada?
Yes. Health Canada lists DIN 00813826 as Marketed as of 28 May 2025.
Who holds the Canadian licence for this product?
Phibro Animal Health Corporation is the company of record in the Health Canada Drug Product Database.
Is Melengestrol Acetate registered outside Canada?
Yes — Nexara Health has matched 1 registration in 1 other market (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00813826, status date 2025-05-28; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00813826, status date 2025-05-28; national medicine registries: FDA NDC.
Health Canada Drug Product Database (DPD), DIN 00813826, status date 2025-05-28; national medicine registries: FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.